By G HossainPosted on October 27, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases. Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition Post navigation Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity AcquisitionDeep Dive: Chinese Biotech Innovation Can’t Be Stopped